W8NB Stock Overview
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AquaBounty Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.34 |
| 52 Week High | US$16.60 |
| 52 Week Low | US$4.15 |
| Beta | 1.31 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -94.10% |
| 5 Year Change | n/a |
| Change since IPO | -89.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| W8NB | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.9% | -1.7% |
| 1Y | n/a | -21.4% | -0.2% |
Return vs Industry: Insufficient data to determine how W8NB performed against the German Biotechs industry.
Return vs Market: Insufficient data to determine how W8NB performed against the German Market.
Price Volatility
| W8NB volatility | |
|---|---|
| W8NB Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: W8NB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine W8NB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 100 | Sylvia Wulf | www.aquabounty.com |
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology.
AquaBounty Technologies, Inc. Fundamentals Summary
| W8NB fundamental statistics | |
|---|---|
| Market cap | €13.87m |
| Earnings (TTM) | -€23.23m |
| Revenue (TTM) | €2.17m |
6.4x
P/S Ratio-0.6x
P/E RatioIs W8NB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W8NB income statement (TTM) | |
|---|---|
| Revenue | US$2.29m |
| Cost of Revenue | US$14.46m |
| Gross Profit | -US$12.16m |
| Other Expenses | US$12.34m |
| Earnings | -US$24.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.87 |
| Gross Margin | -531.06% |
| Net Profit Margin | -1,069.75% |
| Debt/Equity Ratio | 4.9% |
How did W8NB perform over the long term?
See historical performance and comparison